CTI-Biotech took part to the LyonBiopôle 2017 mission in Japan

Scientific IMODI’s Day (nov 23, France)
01/09/2017
Oncodesign will be present at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: October 26-30, Philadelphia, USA, Hall E
MEET IMODI EXPERTS at AACR-NCI-EORTC International Conference (USA, Philadelphia, October 26-30)
15/10/2017

CTI-Biotech took part to the LyonBiopôle 2017 mission in Japan

LyonBiopôle 2017 mission in Japan with CTI Biotech

LyonBiopôle 2017 mission in Japan with CTI Biotech !

Professor Colin McGuckin and Dr Nico Forraz, respectively CSO and CEO of CTI-Biotech are currently taking part to the LyonBiopôle 2017 mission in Japan. They will take part in the 19th BioJapan congress organized in Yokohama city from 11th to 13th of October. The BioJapan conference will host over 900 organizations that are expected to hold approximately 8000 business meetings and is thus the major partnering event in the biotechnology industry in Asia.
For CTI-Biotech this mission is a major opportunity to promote its activities and particularly the cancer cell models produced by the company including products and services developed by the IMODI consortium. Japan is the second healthcare market worldwide and many major Japanese pharmaceutical companies are seeking innovative solutions to accelerate drug development in oncology.

Meet CTI Biotech



Get connected!

IMODI is now present on the Twitter and LinkedIn networks.
Follow us on @IMODI_Cancer and www.linkedin.com/company/imodi-cancer


Share this